Authors: April W. Armstrong; Charles W. Lynde; Sandy R. McBride; Mona Ståhle; Emily Edson-Heredia; Baojin Zhu; David Amato; Enkeleida Nikaï; Fan Emily Yang; Kenneth B. Gordon JAMA Dermatology, June 2016 … Read More
FDA approves new psoriasis drug Taltz
U.S. Food and Drug Administration, March 2016 Release The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition … Read More